세계의 동물용 의약품 조제 시장 보고서(2025년)
Animal Drug Compounding Global Market Report 2025
상품코드 : 1793382
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

동물용 의약품 조제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.4%를 나타내 23억 8,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 규제 동향, 반려동물 사육 동향, 전문적인 수의학, 수의학 서비스의 세계화, 수의학의 진보로 인한 것입니다. 예측기간의 주요 동향으로는 향미와 기호성의 중시, 특수한 제형 수요, 수의사와 제제 약사의 제휴, 통증 관리 솔루션의 중시, 동물용 호스피스 케어에서의 역할의 증대 등이 있습니다.

향후 5년간의 성장률 7.4%라고 하는 예측은 이 시장에 관한 전회의 예측으로부터 변경은 없습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 유당 일수화물 및 무균수와 같은 의약품 등급 부형제에 대한 수입 관세는 틈새 동물 종 및 복용량 요구에 대응하는 미국 동물 의약품 조제 제조 업체의 이익률을 압박할 것으로 보입니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

동물 입양률 증가는 향후 동물용 의약품 조제 시장 성장을 밀어올릴 것으로 예측됩니다. 동물 입양이란 반려동물 가게나 브리더에서 구입하는 것이 아니라 구조 단체를 통해 반려동물을 얻는 것을 말합니다. 입양된 동물은 흔히 기존의 건강 문제를 겪고 있으며, 표준 제형으로는 이용할 수 없는 약물이 필요할 수 있으므로 이러한 동물에 맞게 맞춤화된 약물에 대한 수요가 증가하고 있습니다. 더 많은 반려동물 소유자가 채용 한 반려동물을 위해 맞춤형 약물을 찾는 동물 동물 의약품 조제의 필요성이 높아집니다. 예를 들어 영국에 본사를 둔 금융 서비스 회사인 Novuna는 2023년 10월에 약 10,070마리의 개가 입양되었다고 보고했으며, 이는 2022년에 비해 11.06% 증가했습니다. 그 결과, 동물의 사육률의 상승이 동물용 의약품 조제 시장 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Animal drug compounding involves the process of customizing and altering the ingredients of multiple medicines to create a personalized medication suitable for the specific needs of individual animals or groups of animals. This practice is crucial in veterinary medicine for providing tailored medical treatment to animals.

The primary products of animal drug compounding include anti-infective agents, anti-inflammatory agents, hormones and substitutes, central nervous system (CNS) agents, and other specialized products. Anti-infective agents encompass medications such as antibiotics, antivirals, and antifungals, used to prevent and treat various infections in animals. These agents play a vital role in eliminating infectious germs and controlling the spread of infections among animals. Animal drug compounding is applicable to various types of animals, including companion animals and livestock, and can be administered through different routes such as oral, injectable, topical, among others. This practice is commonly employed in veterinary hospitals, clinics, and diagnostic centers dedicated to veterinary care.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The animal drug compounding market research report is one of a series of new reports from The Business Research Company that provides animal drug compounding market statistics, including animal drug compounding industry global market size, regional shares, competitors with an animal drug compounding market share, detailed animal drug compounding market segments, market trends and opportunities, and any further data you may need to thrive in the animal drug compounding industry. This animal drug compounding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal drug compounding market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to regulatory landscape, veterinary practices, market awareness, limited commercial options, veterinary collaboration.

The animal drug compounding market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to regulatory developments, pet ownership trends, specialized veterinary care, globalization of veterinary services, advancements in veterinary medicine. Major trends in the forecast period include focus on flavoring and palatability, demand for specialized dosage forms, collaboration between veterinarians and compounding pharmacists, focus on pain management solutions, growing role in veterinary hospice care.

The forecast of 7.4% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Import duties on pharmaceutical-grade excipients such as lactose monohydrate and sterile water will squeeze profit margins for U.S. veterinary compounders serving niche species and dosage needs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increase in the rate of animal adoption is anticipated to boost the growth of the animal drug compounding market in the future. Animal adoption refers to acquiring pets through rescue organizations rather than purchasing them from pet stores or breeders. Adopted animals often come with pre-existing health issues or may require medications that are not available in standard formulations, leading to a higher demand for customized medications for these animals. As more pet owners seek tailored medications for their adopted pets, the necessity for animal drug compounding rises. For example, in October 2023, Novuna, a UK-based financial services company, reported that approximately 10,070 dogs were adopted, marking an 11.06% increase compared to 2022. Consequently, the rise in animal adoption rates is driving the growth of the animal drug compounding market.

Increasing pet expenditure is expected to further propel the growth of the animal drug compounding market. Pet expenditure encompasses the total amount spent on various aspects of pet ownership and care. This spending contributes to the demand for tailored medications that address the unique needs of individual animals, thereby encouraging compounding pharmacies to continue offering these specialized services in veterinary care. For instance, in October 2023, the North American Pet Health Insurance Association (NAPHIA), a US-based trade organization, stated that in 2022, pet owners in the United States spent $136.8 billion on their dogs, cats, birds, and other companion animals, with this figure projected to increase to $143.6 billion in 2023. Therefore, the rising pet expenditure is driving the growth of the animal drug compounding market.

Major companies in the animal drug compounding market are creating innovative products, such as feline-friendly formulations, to improve the safety and effectiveness of medications specifically designed for cats. Feline-friendly formulations are products tailored to be safe, effective, and appealing to cats. For instance, in September 2024, Wedgewood, a US-based veterinary pharmaceutical company, launched compounded molnupiravir. This antiviral medication is specifically formulated to treat Feline Infectious Peritonitis (FIP) in cats. Wedgewood offers various dosages of feline-friendly molnupiravir to address different forms of FIP, including effusive, non-effusive, neurological, and ocular types. This includes producing a range of dosages and flavors, such as flavored oral oil suspensions and capsules, to cater to the unique needs of individual feline patients.

Leading entities within the animal drug compounding market are actively engaging in partnerships to bolster their revenues and market positioning. Brava, a tech-driven network of compounding pharmacies, collaborates with veterinarians, offering innovative tools, expert pharmacy support, and exceptional customer care. In October 2022, Veterinary Growth Partners, a prominent US-based veterinary services organization representing over 6,000 veterinary practices, designated Brava as its preferred veterinary compounding pharmacy provider. This partnership strives to enhance personalized care in veterinary compounding, streamline processes to ensure regulatory compliance, and deliver top-notch compounding pharmacy solutions.

In May 2024, MixLab, a US-based pharmaceutical laboratory, acquired Nexgen Animal Health for an undisclosed amount. This acquisition aims to expand MixLab's veterinary compounding services to include large animals while enhancing the pharmacy experience through advanced technology and increased capacity. Nexgen Animal Health, also based in the US, specializes in formulating innovative products and drug compounds for animals.

Major companies operating in the animal drug compounding market include Wedgewood Pharmacy LLC, Triangle Compounding Pharmacy Inc., Davis Islands Pharmacy & Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South LLC, Wellness Compounding Pharmacy of Cary LLC, Miller's Pharmacy, Caringbah Compounding Pharmacy Pty. Ltd., Smith Drug and Compounding Inc., Specialist Compounding Pharmacy Pte Ltd., Tache Pharmacy & Medical Supplies, Hoye's Pharmacy, Vertisis Custom Pharmacy LLC, Smith-Caldwell Drug Store Inc., Sixth Avenue Medical Pharmacy, Pharmaca Integrative Pharmacy Inc., Akina Animal Health, Letco Medical LLC, The Pet Apothecary LLC, Vetsource Inc., Roadrunner Pharmacy, Medisca Inc., BCP Veterinary Pharmacy, VetRxDirect LLC, Diamondback Drugs, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetMed Express Inc., PetRx2Go, South Wellness Pharmacy

North America was the largest region in the animal drug compounding market in 2024. The regions covered in the animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the animal drug compounding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The animal drug compounding market consists of sales of flavored medications, suppositories, and ophthalmic preparations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Drug Compounding Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal drug compounding market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for animal drug compounding ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal drug compounding market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Animal Drug Compounding Market Characteristics

3. Animal Drug Compounding Market Trends And Strategies

4. Animal Drug Compounding Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Animal Drug Compounding Growth Analysis And Strategic Analysis Framework

6. Animal Drug Compounding Market Segmentation

7. Animal Drug Compounding Market Regional And Country Analysis

8. Asia-Pacific Animal Drug Compounding Market

9. China Animal Drug Compounding Market

10. India Animal Drug Compounding Market

11. Japan Animal Drug Compounding Market

12. Australia Animal Drug Compounding Market

13. Indonesia Animal Drug Compounding Market

14. South Korea Animal Drug Compounding Market

15. Western Europe Animal Drug Compounding Market

16. UK Animal Drug Compounding Market

17. Germany Animal Drug Compounding Market

18. France Animal Drug Compounding Market

19. Italy Animal Drug Compounding Market

20. Spain Animal Drug Compounding Market

21. Eastern Europe Animal Drug Compounding Market

22. Russia Animal Drug Compounding Market

23. North America Animal Drug Compounding Market

24. USA Animal Drug Compounding Market

25. Canada Animal Drug Compounding Market

26. South America Animal Drug Compounding Market

27. Brazil Animal Drug Compounding Market

28. Middle East Animal Drug Compounding Market

29. Africa Animal Drug Compounding Market

30. Animal Drug Compounding Market Competitive Landscape And Company Profiles

31. Animal Drug Compounding Market Other Major And Innovative Companies

32. Global Animal Drug Compounding Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Animal Drug Compounding Market

34. Recent Developments In The Animal Drug Compounding Market

35. Animal Drug Compounding Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기